Search Medical Condition
Please enter condition
Please choose location from dropdown

Depression Clinical Trials

A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1225) clinical trials

This study will evaluate the long-term safety and tolerability of rapastinel as an adjunctive to antidepressant therapy (ADT) in patients with major depressive disorder (MDD).

Phase

Adults experiencing depression associated with bipolar disorder have the opportunity to participate in a clinical trial studying the efficacy of a new, investigational medication. Qualified participants will receive study medication and will be closely followed by UC Health staff over 6 weeks.

Phase N/A

The purpose of this study is to test an investigational drug called SAGE-547 (Allopregnolone) to determine if it is safe and has any effect on moderate and/or severe postpartum depression. An investigational drug is one that is not approved by the United States Food and Drug Administration (FDA).

Phase N/A

This study will assess the safety and efficacy of an investigational medication in patients with Major Depressive Disorder who have had a partial response to their antidepressant treatment. Each patient will receive a weekly intravenous dose of the investigational medication in addition to the current dose of their antidepressant.

Phase N/A

Looking for individuals to participate in a nationwide clinical research study of an investigational drug for Major Depressive Disorder and currently taking medication for it.

Phase

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MUTLICENTER STUDY OF RAPASTINEL AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER

Phase

A MULTICENTER, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED PARALLEL-GROUP EVALUATION OF THE SAFETY AND EFFICACY OF VILAZODONE IN PEDIATRIC PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Phase

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF ITI-007 MONOTHERAPY IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR I OR II DISORDER (BIPOLAR DEPRESSION)

Phase

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF ITI-007 ADJUNCTIVE TO LITHIUM OR VALPROATE IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE EPISODES ASSOCIATED WITH BIPOLAR I OR II DISORDER (BIPOLAR DEPRESSION)

Phase

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MUTLICENTER STUDY OF RAPASTINEL AS ADJUNCTIVE THERAPY IN MAJOR DEPRESSIVE DISORDER

Phase